CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
Total |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income (Loss) |
Previously reported |
Previously reported
Common Stock
|
Previously reported
Additional Paid-in Capital
|
Previously reported
Accumulated Deficit
|
Previously reported
Accumulated Other Comprehensive Income (Loss)
|
Retroactive application of recapitalization |
Retroactive application of recapitalization
Common Stock
|
Retroactive application of recapitalization
Additional Paid-in Capital
|
Beginning balance (in shares) at Dec. 31, 2020 |
|
44,461
|
|
|
|
|
9,750
|
|
|
|
|
34,711
|
|
Beginning balance at Dec. 31, 2020 |
$ 24,766
|
$ 4
|
$ 45,890
|
$ (21,128)
|
$ 0
|
$ (20,441)
|
$ 1
|
$ 686
|
$ (21,128)
|
$ 0
|
$ 45,207
|
$ 3
|
$ 45,204
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Business Combination and PIPE Shares, net (in shares) |
|
53,361
|
|
|
|
|
|
|
|
|
|
|
|
Business Combination and PIPE shares, net |
433,527
|
$ 6
|
433,521
|
|
|
|
|
|
|
|
|
|
|
Conversion of Private Warrants |
5,819
|
|
5,819
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise (in shares) |
|
103
|
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise |
35
|
|
35
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
6,287
|
|
6,287
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(28,515)
|
|
|
(28,515)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(669)
|
|
|
|
(669)
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Mar. 31, 2021 |
|
97,925
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Mar. 31, 2021 |
441,250
|
$ 10
|
491,552
|
(49,643)
|
(669)
|
|
|
|
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2020 |
|
44,461
|
|
|
|
|
9,750
|
|
|
|
|
34,711
|
|
Beginning balance at Dec. 31, 2020 |
24,766
|
$ 4
|
45,890
|
(21,128)
|
0
|
$ (20,441)
|
$ 1
|
$ 686
|
$ (21,128)
|
$ 0
|
$ 45,207
|
$ 3
|
$ 45,204
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(77,799)
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(2,578)
|
|
|
|
(2,578)
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Sep. 30, 2021 |
|
100,674
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2021 |
465,440
|
$ 10
|
566,935
|
(98,927)
|
(2,578)
|
|
|
|
|
|
|
|
|
Beginning balance (in shares) at Mar. 31, 2021 |
|
97,925
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2021 |
441,250
|
$ 10
|
491,552
|
(49,643)
|
(669)
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Private Warrants |
3,114
|
|
3,114
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for acquisition of Root AI (in shares) |
|
2,329
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for acquisition of Root AI |
48,991
|
|
48,991
|
|
|
|
|
|
|
|
|
|
|
Issuance of stock options for business combination |
361
|
|
361
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
|
21
|
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units |
(108)
|
|
(108)
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
13,390
|
|
13,390
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(32,016)
|
|
|
(32,016)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(1,843)
|
|
|
|
(1,843)
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2021 |
|
100,275
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Jun. 30, 2021 |
473,139
|
$ 10
|
557,300
|
(81,659)
|
(2,512)
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Private Warrants |
201
|
|
201
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
|
391
|
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units |
(2,233)
|
|
(2,233)
|
|
|
|
|
|
|
|
|
|
|
Warrants exercised (in shares) |
|
8
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exercised |
96
|
|
96
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
11,571
|
|
11,571
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(17,268)
|
|
|
(17,268)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(66)
|
|
|
|
(66)
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Sep. 30, 2021 |
|
100,674
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2021 |
465,440
|
$ 10
|
566,935
|
(98,927)
|
(2,578)
|
|
|
|
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2021 |
|
101,136
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
387,640
|
$ 10
|
576,895
|
(187,314)
|
(1,951)
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Private Warrants |
1,104
|
|
1,104
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise |
36
|
|
36
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
|
414
|
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units |
(953)
|
|
(953)
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
6,035
|
|
6,035
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(30,635)
|
|
|
(30,635)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
4,360
|
|
|
|
4,360
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Mar. 31, 2022 |
|
101,550
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Mar. 31, 2022 |
367,587
|
$ 10
|
583,117
|
(217,949)
|
2,409
|
|
|
|
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2021 |
|
101,136
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
387,640
|
$ 10
|
576,895
|
(187,314)
|
(1,951)
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(83,324)
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
10,671
|
|
|
|
10,671
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Sep. 30, 2022 |
|
107,278
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2022 |
343,315
|
$ 11
|
605,222
|
(270,638)
|
8,720
|
|
|
|
|
|
|
|
|
Beginning balance (in shares) at Mar. 31, 2022 |
|
101,550
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2022 |
367,587
|
$ 10
|
583,117
|
(217,949)
|
2,409
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise (in shares) |
|
762
|
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise |
22
|
|
21
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under the Purchase Agreement (in shares) |
|
3,150
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under the Purchase Agreement |
8,232
|
|
8,232
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for Employee Stock Purchase Plan (in shares) |
|
78
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for Employee Stock Purchase Plan |
211
|
|
211
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
|
197
|
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units |
(369)
|
|
(369)
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
5,993
|
|
5,993
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(28,705)
|
|
|
(28,705)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
2,760
|
|
|
|
2,760
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2022 |
|
105,737
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Jun. 30, 2022 |
355,731
|
$ 11
|
597,205
|
(246,654)
|
5,169
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise (in shares) |
|
338
|
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise |
80
|
|
80
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under the Purchase Agreement (in shares) |
|
360
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under the Purchase Agreement |
1,298
|
|
1,298
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock, net (in shares) |
|
542
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock, net |
1,347
|
|
1,347
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
|
301
|
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units |
(175)
|
|
(175)
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
5,467
|
|
5,467
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(23,984)
|
|
|
(23,984)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
3,551
|
|
|
|
3,551
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Sep. 30, 2022 |
|
107,278
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2022 |
$ 343,315
|
$ 11
|
$ 605,222
|
$ (270,638)
|
$ 8,720
|
|
|
|
|
|
|
|
|